Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Evoke Pharma Inc.

    NASDAQ: EVOK · Real-Time Price · USD
    2.80
    -0.09 (-3.20%)
    At close: Jun 16, 2025, 3:59 PM
    2.53
    -9.64%
    After-hours: Jun 16, 2025, 06:31 PM EDT

    Evoke Pharma Statistics

    Share Statistics

    Evoke Pharma has 1.49M shares outstanding. The number of shares has increased by -82.64% in one year.

    Shares Outstanding

    n/a
    		 1.49M

    Shares Change (YoY)

    n/a
    		 -82.64%

    Shares Change (QoQ)

    n/a
    		 0.46%

    Owned by Institutions (%)

    n/a
    		 6.09%

    Shares Floating

    n/a
    		 1.41M

    Failed to Deliver (FTD) Shares

    n/a
    		 26

    FTD / Avg. Volume

    n/a
    		 0.11%

    Short Selling Information

    The latest short interest is 20.91K, so 1.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 20.91K

    Short % of Shares Out

    n/a
    		 1.4%

    Short % of Float

    n/a
    		 1.58%

    Short Ratio (days to cover)

    n/a
    		 1.47

    Valuation Ratios

    The PE ratio is -1.57 and the forward PE ratio is 1.88. Evoke Pharma's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.57

    Forward PE

    n/a
    		 1.88

    PS Ratio

    n/a
    		 0.82

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 0

    P/FCF Ratio

    n/a
    		 -1.54

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Evoke Pharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 1.66

    Quick Ratio

    n/a
    		 1.62

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 -1.06

    Debt / FCF

    n/a
    		 -0.95

    Interest Coverage

    n/a
    		 -10.38

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $3,416,471.67

    Profits Per Employee

    n/a
    		 $-1,784,064.67

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0.59

    Inventory Turnover

    n/a
    		 0.8

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -55.84% in the last 52 weeks. The beta is 0.03, so Evoke Pharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.03

    52-Week Price Change

    n/a
    		 -55.84%

    50-Day Moving Average

    n/a
    		 2.94

    200-Day Moving Average

    n/a
    		 4.14

    Relative Strength Index (RSI)

    n/a
    		 41.92

    Average Volume (20 Days)

    n/a
    		 23,055

    Income Statement

    In the last 12 months, Evoke Pharma had revenue of 10.25M and earned -5.35M in profits. Earnings per share was -2.81.

    Revenue

    n/a
    		 10.25M

    Gross Profit

    n/a
    		 9.89M

    Operating Income

    n/a
    		 -5.2M

    Net Income

    n/a
    		 -5.35M

    EBITDA

    n/a
    		 -4.85M

    EBIT

    n/a
    		 -4.85M

    Earnings Per Share (EPS)

    n/a
    		 -2.81
    Full Income Statement

    Balance Sheet

    The company has 13.6M in cash and 5.16M in debt, giving a net cash position of 8.44M.

    Cash & Cash Equivalents

    n/a
    		 13.6M

    Total Debt

    n/a
    		 5.16M

    Net Cash

    n/a
    		 8.44M

    Retained Earnings

    n/a
    		 -128.79M

    Total Assets

    n/a
    		 16.38M

    Working Capital

    n/a
    		 5.78M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -5.46M and capital expenditures 0, giving a free cash flow of -5.46M.

    Operating Cash Flow

    n/a
    		 -5.46M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -5.46M

    FCF Per Share

    n/a
    		 -2.87
    Full Cash Flow Statement

    Margins

    Gross margin is 96.52%, with operating and profit margins of -50.77% and -52.22%.

    Gross Margin

    n/a
    		 96.52%

    Operating Margin

    n/a
    		 -50.77%

    Pretax Margin

    n/a
    		 -52.22%

    Profit Margin

    n/a
    		 -52.22%

    EBITDA Margin

    n/a
    		 -47.33%

    EBIT Margin

    n/a
    		 -50.77%

    FCF Margin

    n/a
    		 -53.26%

    Dividends & Yields

    EVOK does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for EVOK.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 1, 2024. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Aug 1, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 -10.61

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist